91大神

Clinical Trial</h3>\r\n<p><b>Offered by:</b> 91大神 Children's<br>\r\n<b>Locations:</b> Delaware Valley and Pensacola in Florida</p>\r\n<h3>Trial Name</h3>\r\n<p>Intergroup Trial for Children or Adolescents With B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients</p>\r\n<h3>What is the trial about?</h3>\r\n<p>To see if using rituximab in combination with the DA-EPOCH chemotherapy will result in improved treatment outcome for children with PMLBL.</p>\r\n<h3>Who can participate?</h3>\r\n<p>6 months to &lt; 18 yrs of age.</p>\r\n<h3>What is involved?</h3>\r\n<p>Length of study is 5 months. In addition to standard NHL care, other tests performed include immune system recovery blood tests and PET scans.</p>\r\n"}} id=text-9ff1b4c3fd class=cmp-text>

Clinical Trial

Offered by: 91大神 Children's
Locations: Delaware Valley and Pensacola in Florida

Trial Name

Intergroup Trial for Children or Adolescents With B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients

What is the trial about?

To see if using rituximab in combination with the DA-EPOCH chemotherapy will result in improved treatment outcome for children with PMLBL.

Who can participate?

6 months to < 18 yrs of age.

What is involved?

Length of study is 5 months. In addition to standard NHL care, other tests performed include immune system recovery blood tests and PET scans.

<strong>Trial Name:</strong> Intergroup Trial for Children or Adolescents with B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients</p>\n<p><strong>COG#:</strong> ANHL1131</p>\n"}} id=text-72b3929fba class=cmp-text>

Trial Name: Intergroup Trial for Children or Adolescents with B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients

COG#: ANHL1131